(Q44683769)

5 December 2017

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography (English)

1 reference

contrast-induced nephropathy

5 December 2017

1 reference

1 reference

1 reference

J Bradley Oldemeyer

1

1 reference

5 December 2017

W Paul Biddle

2

1 reference

5 December 2017

Richard L Wurdeman

3

1 reference

5 December 2017

Aryan N Mooss

4

1 reference

5 December 2017

Erica Cichowski

5

1 reference

5 December 2017

Daniel E Hilleman

6

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

5 December 2017

American Heart Journal

1 reference

5 December 2017

146

1 reference

5 December 2017

E23

1 reference

5 December 2017

6

1 reference

The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Contrast-induced nephrotoxicity in patients undergoing cardiac catheterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Nephrotoxicity of contrast media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Contrast-associated nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Acetylcysteine and contrast agent-associated nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Prediction of creatinine clearance from serum creatinine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900511-8

10.1016/S0002-8703(03)00511-8

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference